Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term in-situ hybridization. Found 8 abstracts

Layfield LJ, Ehya H, Filie AC, Hruban RH, Jhala N, Joseph L, Vielh P, Pitman MB. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The papanicolaou society of cytopathology guidelines for pancreatobiliary cytology. Diagnostic Cytopathology. 2014 Apr;42(4):351-62.   PMCID: No NIH funds
Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, Remzi M, Uzzo RG. Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours. European Urology. 2012 Sep;62(3):491-504.   PMCID: not NIH funded
Carlson RW, Allred C, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R. Invasive Breast Cancer. Journal of the National Comprehensive Cancer Network. 2011 Feb;9(2):136-222.   PMCID: not NIH funded - practice guideline
Hayashi N, Nakamura S, Yagata H, Shimoda Y, Ota H, Hortobagyi GN, Cristofanilli M, Ueno NT. Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case series. International Journal of Clinical Oncology. 2011 Oct;16(5):596-600.   PMCID: *
Pectasides E, Rampias T, Kountourakis P, Sasaki C, Kowalski D, Fountzilas G, Zaramboukas T, Rimm D, Burtness B, Psyrri A. Comparative Prognostic Value of Epidermal Growth Factor Quantitative Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 2011 May;17(9):2947-54.   PMCID: not NIH funded
Fischer AH, Zhao C, Li QK, Gustafson KS, Eltoum IE, Tambouret R, Benstein B, Savaloja LC, Kulesza P. The Cytologic Criteria of Malignancy. Journal of cellular biochemistry. 2010 Jul;110(4):795-811.   PMCID: not NIH funded
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Radich JP, Shah NP, Smith BD, Snyder DS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 2009 Oct;7(9):984-1023.   PMCID: not NIH funded
Agus DB, Bunn PA, Franklin W, Garcia M, Ozols RF. HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer. Seminars in Oncology. 2000 Dec;27(6):53-63.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term in-situ hybridization

in-situ hybridization growth-factor receptor chemotherapy fine-needle-aspiration therapy breast-conserving therapy polymerase-chain-reaction pathological digital image-analysis response rhabdoid tumors radiation mastectomy bone-marrow-transplantation Metastasis copy number alterations dasatinib tyrosine kinase inhibitor clinical management first-line therapy phase-ii trial mucinous neoplasms chronic myelogenous trastuzumab imatinib transplantation amplification gene amplification status quality-of-life tissue microarray analysis sentinel-node biopsy biliary tract fine-needle aspiration egfr gene prognostic-significance randomized controlled-trial complete cytogenetic Polysomy human-breast mammary tumorigenesis breast cancer breast-cancer progression features donor lymphocyte infusions lobular carcinoma in situ ancillary studies patients receiving imatinib radiofrequency ablation cytogenetic her2 EUS receptor progression molecular diagnosis granulosa-cell tumors gene amplification poor-prognosis skin-sparing mastectomy cell carcinoma Breast neoplasm acinar cell-carcinoma chronic myeloid-leukemia survival bile-duct strictures multivariate-analysis placebo-controlled trial phase-ii human adjuvant therapy Circulating tumor cell localization tyrosine k-ras mutations endocrine therapy papillary thyroid-carcinoma cyst fluid analysis core biopsy computed-tomography nilotinib papillary karyotyping xenograft models imatinib mesylate stem-cell transplantation tumor-suppressor gene endobiliary brush cytology plus cetuximab active surveillance leukemia colorectal-cancer proliferative activity kinase Renal mass Needle core biopsy-Renal cell carcinoma-Diagnosis-Prognosis-Molecular markers-Cytogenetic markers breast diagnosis cancer cell structure-criteria of malignancy surgical adjuvant follow-up c-myc sideroblastic anemia phase-iii trial pancreas hematologic response messenger-rna HER2 ductal carcinoma in situ aneusomy nuclear-membrane protein allogenic HSCT NCCN Guidelines adjuvant imaging-guided biopsy NCCN Clinical Practice Guidelines image-analysis
Last updated on Thursday, April 02, 2020